Table 3.
Risk factors | mWAI <P15 n/N | Pre-valence [%] | Prevalence difference[%] | Odds ratio (95% confidence interval) | |
---|---|---|---|---|---|
Sex | Male | 442/3912 | 11.3 | 0 | 1 |
Female | 775/5407 | 14.3 | 3.0 | 1.3 (1.2; 1.5) | |
Age [years] | <30 | 102/1490 | 6.8 | 0 | 1 |
30-<40 | 154/1789 | 8.6 | 1.7 | 1.2 (0.9; 1.6) | |
40-<50 | 243/1766 | 13.8 | 6.9 | 1.9 (1.4; 2.5) | |
50-<60 | 471/3027 | 15.6 | 8.7 | 1.9 (1.5; 2.5) | |
≥60 | 247/1247 | 19.8 | 13.0 | 2.6 (1.9; 3.4) | |
Education [years] | <12 | 441/4525 | 16.2 | 6.5 | 1.2 (1.0; 1.3) |
≥12 | 774/4769 | 9.7 | 0 | 1 | |
Marital status | Married/living together | 846/6403 | 13.2 | 0 | 1 |
Single | 258/2323 | 11.1 | -2.1 | 1.2 (1.0; 1.4) | |
Living apart | 68/314 | 21.7 | 8.5 | 1.4 (1.0; 1.9) | |
Widowed | 21/107 | 19.6 | 6.4 | 1.0 (0.6; 1.7) | |
Nationality | German | 1128/8801 | 12.8 | 0 | 1 |
Other | 89/507 | 17.6 | 4.7 | 1.4 (1.1; 1.8) | |
Smoking | Never | 670/5860 | 11.4 | 0 | 1 |
Current | 152/968 | 15.7 | 4.3 | 1.2 (1.1; 1.4) | |
Former | 391/2468 | 15.8 | 4.4 | 1.5 (1.2; 1.9) | |
Obese (body mass index >30 kg/m2) | No | 846/7425 | 11.4 | 0 | 1 |
Yes | 362/1822 | 19.9 | 8.5 | 1.5 (1.3; 1.7) | |
Work demands | Mainly mental | 446/4494 | 9.9 | 0 | 1 |
Mental and physical | 624/3932 | 16.5 | 6.0 | 1.5 (1.3; 1.7) | |
Mainly physical | 147/893 | 15.9 | 6.5 | 1.5 (1.2; 1.8) | |
Medical treatment during acute infection | No treatment | 598/7044 | 8.5 | 0 | 1 |
Outpatient Treatment | 501/1861 | 26.9 | 18.4 | 3.6 (3.1; 4.1) | |
Inpatient Treatment | 76/265 | 28.7 | 20.2 | 3.7 (2.8; 4.9) | |
Admission to intensive care unit | 31/69 | 44.9 | 36.4 | 6.7 (4.0; 11.2) |
mWAI: work ability index modified; P15: 15th percentile for the model we only included the most prevalent seven symptom clusters, irrespective of mWAI<P15; clusters of symptoms (not present before the acute SARS-Cov-2 infection); bold letters indicate statistical significance P <0.05.
a: adjusted for sex, age, education, marital status, nationality, smoking, obesity, work demands, and medical treatment during acute infection; a prevalence difference of 0 indicates the comparison group.